Analyst Price Targets — AVAH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 12, 2026 6:55 pm | David MacDonald | Truist Financial | $10.00 | $7.00 | StreetInsider | Truist Securities Reiterates Hold Rating on Aveanna Healthcare Holdings Inc (AVAH) amid acquisition |
| January 16, 2026 10:58 am | — | Barclays | $11.00 | $9.76 | TheFly | Aveanna price target raised to $11 from $9 at Barclays |
| January 15, 2026 1:31 pm | — | RBC Capital | $11.00 | $9.39 | TheFly | Aveanna price target raised to $11 from $10 at RBC Capital |
| January 15, 2026 1:11 pm | — | UBS | $10.00 | $9.37 | TheFly | Aveanna price target raised to $10 from $9.50 at UBS |
| December 5, 2025 11:06 am | John Ransom | Raymond James | $13.00 | $9.14 | StreetInsider | Aveanna Healthcare Holdings Inc (AVAH) PT Raised to $13 at Raymond James |
| October 28, 2025 12:29 pm | — | Jefferies | $12.50 | $9.70 | TheFly | Aveanna price target raised to $12.50 from $11 at Jefferies |
| October 23, 2025 8:12 pm | Ben Hendrix | RBC Capital | $10.00 | $9.12 | TheFly | Aveanna price target raised to $10 from $8 at RBC Capital |
| October 14, 2025 1:19 pm | — | Truist Financial | $9.50 | $8.88 | TheFly | Aveanna price target raised to $9.50 from $6.50 at Truist |
| October 13, 2025 12:02 pm | — | UBS | $9.00 | $8.65 | TheFly | Aveanna price target raised to $9 from $8 at UBS |
| August 11, 2025 9:08 am | John Ransom | Raymond James | $9.00 | $6.14 | TheFly | Aveanna upgraded to Outperform from Market Perform at Raymond James |
Latest News for AVAH
The mean of analysts' price targets for Aveanna (AVAH) points to a 43.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Small-cap stocks have outperformed amid a rotation away from mega caps, despite geopolitical uncertainty and shifting interest rate expectations. Small-cap firms may benefit from the next phase of AI adoption as productivity gains broaden across industries. Wells Fargo estimates that each 1% reduction in labor costs could translate into a 6.1% earnings increase for Russell 2000 companies.
Aveanna Healthcare Holdings (AVAH) is upgraded to Buy, reflecting improved profitability and resilient demand for home healthcare services. AVAH's Q4 2025 net income surged, but adjusted EPS was $0.17 due to one-time tax benefits and merger costs. FY 2026 revenue guidance of $2.54–$2.56 billion disappointed, while adjusted EBITDA guidance slightly exceeded consensus.
Aveanna Healthcare (NASDAQ: AVAH) reported fourth-quarter and full-year 2025 results that management said reflected continued progress in its preferred payer strategy, improving labor trends, and rate initiatives across its home- and community-based care platform. Executives also provided initial commentary on a newly announced acquisition and issued 2026 guidance that excludes any contribution from the pending deal.
Aveanna Healthcare Holdings Inc. (AVAH) Q4 2025 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AVAH.
U.S. House Trading
No House trades found for AVAH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.